Financhill
Buy
72

GILD Quote, Financials, Valuation and Earnings

Last price:
$109.92
Seasonality move :
2.19%
Day range:
$109.46 - $112.56
52-week range:
$62.07 - $119.96
Dividend yield:
2.76%
P/E ratio:
303.41x
P/S ratio:
4.91x
P/B ratio:
7.23x
Volume:
9.3M
Avg. volume:
9.2M
1-year change:
52.34%
Market cap:
$139.8B
Revenue:
$28.8B
EPS (TTM):
$0.37

Earnings Data

Next earnings date for GILD
Apr 24
2025
Most recent earnings per share
$1.42
Missed by $0.28
(Feb 11/2025)
Consensus Estimate
$1.70
(Feb 11/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GILD Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
04/24/2025 Q1 $6.8B -- -- $1.75 --
02/11/2025 Q4 $7.2B $7.6B $1.42 $1.70 -$0.28
11/06/2024 Q3 $7B $7.5B $1.00 $1.55 -$0.55
08/08/2024 Q2 $6.7B $7B $1.29 $1.60 -$0.31
04/25/2024 Q1 $6.3B $6.7B -$3.34 -$1.52 -$1.82
02/06/2024 Q4 $7.1B $7.1B $1.14 $1.76 -$0.62
11/07/2023 Q3 -- -- $1.73 $1.92 -$0.19
08/03/2023 Q2 -- -- $0.83 $1.64 -$0.81
04/27/2023 Q1 -- -- $0.80 $1.54 -$0.74
02/02/2023 Q4 -- -- $1.30 $1.51 -$0.21
10/27/2022 Q3 -- -- $1.42 $1.43 -$0.01
08/02/2022 Q2 -- -- $0.91 $1.52 -$0.61
04/28/2022 Q1 -- -- $0.02 $1.81 -$1.79
02/01/2022 Q4 -- -- $0.30 $1.61 -$1.31
10/28/2021 Q3 -- -- $2.05 $1.78 $0.27
07/29/2021 Q2 -- -- $1.21 $1.75 -$0.54
04/29/2021 Q1 -- -- $1.37 $2.11 -$0.74
02/04/2021 Q4 -- -- $1.23 $2.15 -$0.92
10/28/2020 Q3 -- -- $0.29 $1.89 -$1.60
07/30/2020 Q2 -- -- -$2.66 $1.45 -$4.11
04/30/2020 Q1 -- -- $1.22 $1.56 -$0.34
02/04/2020 Q4 -- -- $2.12 $1.67 $0.45
10/24/2019 Q3 -- -- -$0.92 $1.73 -$2.65
07/30/2019 Q2 -- -- $1.82 $1.71 $0.11
05/02/2019 Q1 -- -- $1.76 $1.60 $0.16
02/04/2019 Q4 -- -- $1.44 $1.69 -$0.25
10/25/2018 Q3 -- -- $1.84 $1.63 $0.21
07/25/2018 Q2 -- -- $1.91 $1.56 $0.35
05/01/2018 Q1 -- -- $1.48 $1.67 -$0.19
02/06/2018 Q4 -- -- $1.78 $1.67 $0.11
10/26/2017 Q3 -- -- $2.27 $2.13 $0.14
07/26/2017 Q2 -- -- $2.56 $2.17 $0.39
05/02/2017 Q1 -- -- $2.23 $2.28 -$0.05
02/07/2017 Q4 -- -- $2.64 $2.31 $0.33
11/01/2016 Q3 -- -- $2.70 $2.74 -$0.04
07/25/2016 Q2 -- -- $3.03 $3.02 $0.01
04/28/2016 Q1 -- -- $2.98 $3.03 -$0.05
02/02/2016 Q4 -- -- $3.27 $2.91 $0.36
10/27/2015 Q3 -- -- $3.19 $3.03 $0.16
07/28/2015 Q2 -- -- $3.10 $2.83 $0.27
04/30/2015 Q1 -- -- $2.89 $2.78 $0.11

Gilead Sciences Earnings Questions

  • How Much did Gilead Sciences Generate in Revenue Last Quarter?

    Gilead Sciences reported $7.6B worth of top line sales in its most recent quarter.

  • Did Gilead Sciences Beat Earnings Last Quarter?

    Gilead Sciences announced earnings per share of $1.42 which represents a miss of analyst forecast a $1.70 per share.

  • Is Gilead Sciences Profitable?

    Gilead Sciences reported $6B that represents $4.68 per share over the last quarter.

  • What is the Analyst Consensus for Gilead Sciences EPS Next Year?

    Gilead Sciences's earnings are forecast to grow from $0.38 per share to $4.41 per share next year representing an increase of 1991.1%.

  • When is Gilead Sciences's Earnings Date?

    Gilead Sciences's next earnings date is April 24, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock